A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC

Clinical trial NCT01798485 · TERMINATED

Trial details

NCT number: NCT01798485
Sponsor: Synta Pharmaceuticals Corp.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small-Cell Lung Adenocarcinoma Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Metastatic

Start date: 2013-04-01
Primary completion: 2015-12-01
Enrollment: 696

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.